Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
navitoclax (1 trial)
Carcinoma, Ovarian Epithelial (Phase 2)
Ovarian Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (1 total)